| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |